Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(3.47)
# 858
Out of 4,784 analysts
27
Total ratings
58.33%
Success rate
17.63%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYEN Eyenovia | Downgrades: Neutral | n/a | $1.13 | - | 1 | Nov 18, 2024 | |
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $306.97 | +12.06% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $11.20 | +377.68% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $39.86 | +0.35% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $15.09 | +98.81% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $4.93 | +72.41% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $8.01 | +99.75% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $3.08 | +34,672.73% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $17 → $23 | $0.27 | +8,352.77% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $3.28 | +1,454.88% | 1 | Dec 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $6.48 | +146.91% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $4.58 | +882.53% | 1 | Jan 22, 2020 |
Eyenovia
Nov 18, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.13
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $306.97
Upside: +12.06%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $11.20
Upside: +377.68%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $39.86
Upside: +0.35%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $15.09
Upside: +98.81%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $4.93
Upside: +72.41%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $8.01
Upside: +99.75%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $3.08
Upside: +34,672.73%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $17 → $23
Current: $0.27
Upside: +8,352.77%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $3.28
Upside: +1,454.88%
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $6.48
Upside: +146.91%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $4.58
Upside: +882.53%